Blood vessels made from patients' cells

Apr 24, 2009 By MARIA CHENG , AP Medical Writer
In this image released by Cytograft Tissue Engineering on Thursday April 23, 2009 shows a blood vessel prior to implantation, with the blue ‘suture’ thread used to attach it to the patient’s circulation. Scientists have grown blood vessels for kidney patients from their own cells for the first time, a new study says. Other experts called the news "a revolutionary milestone" and said it could lead to doctors one day custom-producing vessels for patients with circulatory problems in their hearts or legs. (AP Photo/Cytograft Tissue Engineering, HO)

(AP) -- Scientists have grown blood vessels for kidney patients from their own cells, making it easier and safer for them to use dialysis machines, a new study says.

Some experts said the results suggested that doctors might one day be able to custom-produce blood vessels for patients with circulatory problems in their hearts or legs. Todd McAllister of Cytograft in California and colleagues implanted lab-grown blood vessels into 10 patients with advanced kidney disease in Argentina and Poland from 2004 to 2007.

Early results for two of these patients were announced in 2005. In 2007, the scientists published preliminary findings for another 4 patients in the .

In this most recent study, published Friday in the medical journal , scientists reported on the new blood vessels in those same patients and 4 others.

Dialysis patients need a vessel, or shunt, to connect them to dialysis machines. This can be made from their own vessels. But because dialysis is done so regularly, often run out of healthy vessels and need an artificial one, often made out of gortex. Those are prone to infection and inflammation.

In the study, doctors took a small snippet of skin from patients. Cells from those samples were grown in a lab, to help them produce proteins like elastin and collagen. From those, scientists made sheets of tissue that were rolled into blood vessels 6 to 8 inches (15 to 20 centimeters) long.

The vessels were finished after 6 to 9 months. All of the vessels were implanted into patients' upper arms, to connect them to dialysis machines.

The vessels failed in three of the patients, which experts said was not surprising in patients so seriously ill. One other patient withdrew from the study and another died of unrelated causes.

In the five remaining patients, the vessels worked for at least 6 to 20 months after they were implanted. Afterwards, those patients needed fewer interventions, including surgeries, to maintain the vessels than regular dialysis patients.

McAllister said he and colleagues plan to test similar devices in patients with heart and leg problems. "It's basically a piece of plumbing to bypass blockages," he said.

The study was was paid for by Cytograft Tissue Engineering.

"This technology is very, very promising," said Vladimir Mironov of the Medical University of South Carolina, who co-wrote an accompanying commentary in the Lancet that praised the study as "a revolutionary milestone."

"It's difficult to predict what will happen next, but they are on the right track," Mironov said. He added the same technique might be useful for people with heart, leg or hernia problems. But Mironov worried the vessels, which cost between $15,000 and $20,000, might be too expensive to be used widely.

Dr. Bryan Becker, president of the National Kidney Foundation in the U.S., said about half of kidney could benefit from these vessels if further tests confirm they work. Becker was not linked to the Lancet study.

---

On the Net:

http://www.lancet.com

http://www.cytograft.com

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Better living through mitochondrial derived vesicles

add to favorites email to friend print save as pdf

Related Stories

Lab-grown body organs are transplanted

Apr 04, 2006

The first human recipients of laboratory-grown organs have been reported at Wake Forest University School of Medicine in Winston-Salem, N.C.

Recommended for you

Student seeks to improve pneumonia vaccines

3 hours ago

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

4 hours ago

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

Better living through mitochondrial derived vesicles

Aug 19, 2014

(Medical Xpress)—As principal transformers of bacteria, organelles, synapses, and cells, vesicles might be said to be the stuff of life. One need look no further than the rapid rise to prominence of The ...

Zebrafish help to unravel Alzheimer's disease

Aug 19, 2014

New fundamental knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain. A new study by scientists at ...

Engineering new bone growth

Aug 19, 2014

MIT chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or defects, this coated scaffold ...

User comments : 0